This is a regulatory disclosure intimation submitted to the BSE Limited and the National Stock Exchange of India Limited.
The Board of Directors of Solara Active Pharma Sciences Limited is scheduled to meet on Thursday, July 23, 2026. The primary agenda for this meeting is to consider and approve the company's unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026. The notice mentions the board will also consider "amongst other matters."
In accordance with the company's Code of Conduct for Prohibition of Insider Trading, which is based on the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities has been closed for all designated persons. The closure period is from July 01, 2026, and will remain in effect until 48 hours after the financial results are officially announced to the public.
The disclosure was signed and submitted by Pooja Jaya Kumar, who holds the position of Company Secretary & Compliance Officer (Membership No: A57415).
The intimation concludes by stating that this information is also available on the company's website at www.solara.co.in.